Luciane Tsukamoto Kagohara

Closest collaborators

The 25 strongest of 74 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elana Judith Fertig · 11 shared papers, 2022–2026 · strength 1.88
   • Paper Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in … DOI 10.64898/2026.03.03.709150↗
   • Paper Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasi… DOI 10.1126/scitranslmed.ady7524↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
2. Elizabeth M. Jaffee · 10 shared papers, 2021–2026 · strength 1.58
   • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
   • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
3. Won Jin Ho · 9 shared papers, 2021–2026 · strength 1.56
   • Paper Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in … DOI 10.64898/2026.03.03.709150↗
   • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
4. Dimitrios N. Sidiropoulos · 7 shared papers, 2022–2026 · strength 1.15
   • Paper Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in … DOI 10.64898/2026.03.03.709150↗
   • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
   • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
5. Jacob T. Mitchell · 7 shared papers, 2022–2026 · strength 1.14
   • Paper Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasi… DOI 10.1126/scitranslmed.ady7524↗
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+ Fibroblasts and Basal Subtype Tumor Cells. DOI 10.1158/1078-0432.ccr-24-2183↗
6. Robert A. Anders · 5 shared papers, 2024–2026 · strength 0.89
   • Paper Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasi… DOI 10.1126/scitranslmed.ady7524↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
   • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
7. Lei Zheng · 6 shared papers, 2021–2026 · strength 0.84
   • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
   • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
   • Paper Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancrea… DOI 10.1101/2024.09.22.613714↗
8. Mark M. Yarchoan · 5 shared papers, 2021–2026 · strength 0.82
   • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
   • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
9. Katherine M. Bever · 4 shared papers, 2024–2026 · strength 0.74
   • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
   • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
   • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
10. Jae Woo Lee · 4 shared papers, 2024–2026 · strength 0.70
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
11. Jacquelyn W. Zimmerman · 5 shared papers, 2021–2026 · strength 0.70
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
12. Janelle Marie Montagne · 4 shared papers, 2024–2026 · strength 0.69
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
    • Paper CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer cl… DOI 10.1016/j.isci.2024.111569↗
13. Marina Baretti · 4 shared papers, 2021–2026 · strength 0.68
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
14. Neeha Zaidi · 4 shared papers, 2021–2026 · strength 0.68
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
15. Nilofer Saba Azad · 4 shared papers, 2021–2026 · strength 0.68
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
16. Amanda L. Huff · 4 shared papers, 2021–2026 · strength 0.68
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
17. Laura DeLong Wood · 4 shared papers, 2022–2026 · strength 0.68
    • Paper Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in … DOI 10.64898/2026.03.03.709150↗
    • Paper Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasi… DOI 10.1126/scitranslmed.ady7524↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
18. Hao Wang · 3 shared papers, 2026 · strength 0.58
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
19. Saurav Daniel Haldar · 3 shared papers, 2026 · strength 0.58
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
20. Daniel A. Laheru · 3 shared papers, 2026 · strength 0.58
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial. DOI 10.1038/s41467-026-68324-4↗
    • Paper Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial DOI 10.1038/s41467-026-71968-x↗
21. Jin Peng He · 4 shared papers, 2021–2026 · strength 0.53
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
22. Samantha R. Guinn · 4 shared papers, 2021–2026 · strength 0.53
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
23. Richard Andrew Burkhart · 4 shared papers, 2021–2026 · strength 0.53
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture DOI 10.1101/2022.07.14.500096↗
24. Daniel J. Zabransky · 3 shared papers, 2021–2026 · strength 0.42
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗
    • Paper Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Infla… DOI 10.1158/0008-5472.can-23-1660↗
    • Paper Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplet… DOI 10.1080/2162402x.2021.2001159↗
25. Michael Goggins · 2 shared papers, 2026 · strength 0.39
    • Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
    • Paper Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancrea… DOI 10.1158/0008-5472.can-25-0331↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.